ArticleFrontiers in nutrition2026
Bioelectrical impedance-derived phase angle as a contextual indicator for steatotic liver disease and hepatic fat estimation.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Steatotic liver disease (SLD) is highly prevalent among individuals with metabolic risk factors, highlighting the need for accessible, non-invasive tools that can support nutritional and clinical risk contextualization. Phase angle, derived from bioelectrical impedance analysis, reflects cellular integrity and body composition and is widely used in nutritional assessment. In this cross-sectional study, 495 adults underwent multi-frequency bioelectrical impedance analysis and hepatic fat evaluation using the controlled attenuation parameter obtained by FibroScan®. Participants were classified as having SLD based on a controlled attenuation parameter threshold of ≥275 dB/m. Individuals with SLD exhibited significantly higher whole-body and segmental phase angle values compared with those without SLD, and these differences were consistent across age and obesity subgroups (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.